Health & Nutrition

bg
Eli Lilly says it will invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

Eli Lilly says it will invest $1.8 billion to expand manufacturing...

Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last...

bg
Gilead says its twice-yearly shot cut HIV infections by 96% in trial

Gilead says its twice-yearly shot cut HIV infections by...

The data sets the stage for likely approval of Gilead's lenacapavir for HIV prevention.

bg
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program

Digital health company Noom to offer compounded GLP-1 drug...

Digital health company Noom is offering compounded GLP-1 drugs to patients in new...

bg
Apple turning AirPods into hearing aids underscores effort to crack massive health market

Apple turning AirPods into hearing aids underscores effort...

Apple is using its newest AirPods Pro as a way to help break into the health industry,...

bg
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

Eli Lilly to invest $1.8 billion to expand manufacturing...

Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last...

bg
Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027

Moderna shares plunge on plans to cut $1.1 billion in costs,...

Moderna is deprioritizing certain parts of its pipeline, which involves pausing...

bg
Gilead's twice-yearly shot cut HIV infections by 96% in trial

Gilead's twice-yearly shot cut HIV infections by 96% in...

The data sets the stage for likely approval of Gilead's Lenacapavir for HIV prevention.

bg
Creatinine to Normalize Homocysteine in Vegetarians? 

Creatinine to Normalize Homocysteine in Vegetarians? 

What are the consequences of having to make your creatine rather than relying on...

bg
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs

Healthy Returns: More than 50 million privately insured...

A large swath of insured Americans could be eligible for a popular class of weight...

bg
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fall 5% on disappointing lung cancer...

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in...